CHF

Canadian visits to US cities plunge 42% amid trade tensions. Tourism sector faces valuation hit.

Petrobras' Q1 profit dips 7.2% YoY despite record output. Brent up 27%, but pricing lags.

CVX beats revenue/EPS, but margin drops 3.4%. Upstream shines, downstream hit by price hikes. Buy?

ESTA founder sells $7.9M shares; 1-yr return 111%. Focus on US growth & reconstruction approval.

Proto Labs beats Q1 estimates with 10% revenue growth, but macro fears weigh. Is it a buy?

Santos' $160M PNG LNG project targets >50% IRR & <4yr payback. Brownfield expansion boosts capacity.

Moderna's revenue soars on UK deals, but litigation weighs. Costs down 26%, yet losses persist. Buy MRNA?